Skip to main content
logo
Immuno-Biological Laboratories Co., Ltd. (TYO:4570)
Japan flag Japan · Delayed Price · Currency is JPY
1,516.00
-26.00 (-1.69%)
At close: Feb 6, 2026

TYO:4570 Income Statement

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Revenue
1,010969816794647602
Revenue Growth (YoY)
12.85%18.75%2.77%22.72%7.47%4.51%
Cost of Revenue
315335300268271256
Gross Profit
695634516526376346
Selling, General & Admin
287300282289310320
Research & Development
119119129179188267
Operating Expenses
412425406474498587
Operating Income
28320911052-122-241
Interest Expense
-1-1-1-1--
Interest & Investment Income
---1--
Earnings From Equity Investments
----203-152-90
Currency Exchange Gain (Loss)
2-38434
Other Non Operating Income (Expenses)
1157122817
EBT Excluding Unusual Items
295210124-135-243-310
Gain (Loss) on Sale of Investments
----130--
Asset Writedown
----14-7-
Other Unusual Items
----1--
Pretax Income
295210124-280-250-310
Income Tax Expense
-24-39-62988
Earnings From Continuing Operations
319249186-289-258-318
Net Income
319249186-289-258-318
Net Income to Common
319249186-289-258-318
Net Income Growth
38.09%33.87%----
Shares Outstanding (Basic)
999999
Shares Outstanding (Diluted)
999999
Shares Change (YoY)
-----5.95%
EPS (Basic)
34.2526.7419.97-31.03-27.70-34.14
EPS (Diluted)
34.2526.7419.97-31.03-27.70-34.14
EPS Growth
38.09%33.87%----
Free Cash Flow
22812411726-93-207
Free Cash Flow Per Share
24.4813.3112.562.79-9.99-22.23
Gross Margin
68.81%65.43%63.23%66.25%58.11%57.48%
Operating Margin
28.02%21.57%13.48%6.55%-18.86%-40.03%
Profit Margin
31.58%25.70%22.79%-36.40%-39.88%-52.82%
Free Cash Flow Margin
22.57%12.80%14.34%3.28%-14.37%-34.38%
EBITDA
300224112---
EBITDA Margin
29.70%23.12%13.73%---
D&A For EBITDA
17152---
EBIT
28320911052-122-241
EBIT Margin
28.02%21.57%13.48%6.55%-18.86%-40.03%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.